Sabril®

Reaching neurologists with a new antiepilepsy option

Sabril can help bring hope to patients suffering from the most challenging types of seizures, but it also carries a black box and the risk of a significant side effect. To address this challenging launch situation, we made patient identification the cornerstone of the brand's launch strategy. The "Which of your patients will Sabril fit?" campaign, featuring real Sabril patients, launched in both print and electronic media. It is also supported by SHARE (Support, Help And Resources for Epilepsy), a branded REMS program that helps both patients and physicians navigate the treatment program.

Sabril Print Ad
Sabril iPad Sales Aid
Sabril SHARE Program